Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • TD Cowen 44th Annual Health Care Conference, Boston Fireside chat on Monday, March 4, 2024 at 1:30 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Nathan Harrill Exact Sciences Corp. investorrelations@exactsciences.com 608-535-8659

EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more EXACT Sciences Charts.
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more EXACT Sciences Charts.